TG Therapeutics Inc
Change company Symbol lookup
Select an option...
TGTX TG Therapeutics Inc
ESUS ETRACS 2x Leveraged MSCI USA ESG Focus TR ETN
BSRR Sierra Bancorp
CO Global Cord Blood Corp
AHT-G Ashford Hospitality Trust Inc
LUVU Luvu Brands Inc
MYD BlackRock MuniYield
NMG Nouveau Monde Graphite Inc
VLYPO Valley National Bancorp
PEPL PepperLime Health Acquisition Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

TG Therapeutics, Inc. (TG) is a fully integrated, commercial stage biopharmaceutical company, which is focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. Its pipeline candidates include TG-1501 (Cosibelimab), TG-1701 (BTK inhibitor), TG-1801 (anti-CD47/anti-CD19 bispecific monoclonal antibody). Its UKONIQ (umbralisib) is developed for the treatment of adult patients with relapsed or refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed or refractory follicular lymphoma. It has three programs in Phase III development for the treatment of patients with relapsing forms of multiple sclerosis and patients with chronic lymphocytic leukemia and several investigational medicines in Phase I clinical development. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.

Closing Price
$5.92
Day's Change
-0.07 (-1.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.42
Day's Low
5.86
Volume
(Below Average)
Volume:
2,058,187

10-day average volume:
2,546,810
2,058,187
  • Prev Close
    5.99
  • Today's Open
    5.94
  • Day's Range
    5.86-6.42
  • Avg Vol (10-day)
    2.5M
  • Last (time)
    4:00p ET 09/30/22
  • Last (size)
    10
  • 52-Wk Range
    3.48 - 35.94
    LowHigh
  • (11/08/21 - 06/16/22)
    70.11%
  • 118.9%
  • Market Cap
    860.0M
  • Shares Outstanding
    145.3M
  • -2.17
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.2
  • 69.83
  • (% of float 09/15/22)
    13.29

Latest News

September 16, 2022
1:36 pm ET
Accesswire
1:00 pm ET
Accesswire
11:45 am ET
Accesswire
11:12 am ET
PR Newswire
11:00 am ET
BusinessWire
10:30 am ET
Accesswire
9:15 am ET
Newsfile
5:45 am ET
PR Newswire
September 15, 2022
10:42 pm ET
PR Newswire
7:15 pm ET
Accesswire
5:41 pm ET
Globe Newswire
12:30 pm ET
Accesswire
12:01 pm ET
Accesswire
11:01 am ET
Accesswire
10:13 am ET
Accesswire
9:36 am ET
Accesswire
9:13 am ET
Newsfile
5:45 am ET
PR Newswire
1:46 am ET
Newsfile
September 14, 2022
9:42 pm ET
BusinessWire
9:35 pm ET
Newsfile
9:25 pm ET
Globe Newswire
8:05 pm ET
Newsfile
3:01 pm ET
Accesswire
2:21 pm ET
Newsfile
1:18 pm ET
Accesswire
1:17 pm ET
Accesswire
12:34 pm ET
Accesswire
9:16 am ET
Accesswire
8:39 am ET
Newsfile
5:45 am ET
PR Newswire
September 13, 2022
8:45 pm ET
Newsfile
7:16 pm ET
Accesswire
5:46 pm ET
Accesswire
4:47 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.